Exploring the Mechanism of Action of the "Scutellaria Barbata D.Don-Prunella Vulgaris L." Herb Pair in the Treatment of Lung Cancer Using Network Pharmacology and Molecular Docking Techniques

Authors

  • Hongzhi Liu Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi, China
  • Le Han Shaanxi Provincial Cancer Hospital, Xi'an 710061, Shaanxi, China

DOI:

https://doi.org/10.53469/jcmp.2024.06(09).26

Keywords:

Scutellaria barbata D.Don, Prunella vulgaris L., Network pharmacology, AkT1

Abstract

Objective: To explore the mechanism of action of the herbal pair "Scutellaria barbata D.Don-Prunella vulgaris L." in the treatment of lung cancer through network pharmacology and molecular docking techniques. Methods: Active ingredients and their targets of Scutellaria barbata D.Don and Prunella vulgaris L. were collected and screened from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP). Disease-related targets were obtained and screened from the Genecards and OMIM databases. The intersection Venn diagram of the targets of "Scutellaria barbata D.Don-Prunella vulgaris L." and lung cancer disease targets was obtained using R 4.4.1 software and packages such as "ggvenn". A drug-active ingredient-target-disease association network was constructed in Cytoscape 3.10.0, and core active ingredients were screened using the Analyze Network function. A PPI network for drug-disease common targets was constructed using the String database website, and the TSV format of protein interaction relationship files was imported into Cytoscape 3.10.0 software,install and run CytoHubba to calculate and obtain the core targets in the network. GO function and KEGG pathway enrichment analyses were performed on drug-disease common targets using R 4.4.1 software. Finally, molecular docking validation was performed on core ingredients and core targets using AutoDock, and the three best binding molecular docking patterns were displayed using PyMol software. Results: A total of 33 active drug components and 108 drug-disease common targets were obtained. Among them, there are 5 core active components: quercetin, luteolin, wogonin, kaempferol, and baicalein; core targets include TP53, AKT1, JUN, HSP90AA1, etc. GO analysis yielded 2, 010 related entries. KEGG analysis identified 147 signaling pathways. Molecular docking showed that the core active components have strong affinity with the core targets. Conclusion: The drug pair of Scutellaria barbata D.Don and Prunella vulgaris L. may exert anti-tumor effects by acting on targets such as TP53, AKT1, JUN, HSP90AA1, and through signaling pathways like PI3K-AKT, inhibiting tumor cell proliferation, promoting tumor cell apoptosis, suppressing its proliferation, differentiation, and metastasis, thereby achieving therapeutic effects on lung cancer.

References

XIA C, DONG X, LI H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J (Engl), 2022, 135(5): 584-590.

LEE J H, SAXENA A, GIACCONE G. Advancements in small cell lung cancer[J]. Semin Cancer Biol, 2023, 93: 123-128.

GRANT C, HAGOPIAN G, NAGASAKA M. Neoadjuvant therapy in non-small cell lung cancer[J]. Crit Rev Oncol Hematol, 2023, 190: 104080.

LI Z, FEIYUE Z, GAOFENG L. Traditional Chinese medicine and lung cancer--From theory to practice[J]. Biomed Pharmacother, 2021, 137: 111381.

Zhou Weiwei, Tang Wei, Pan Bo, et al. Research on the prescription rules of national master of Chinese medicine PAN Minqiu in the treatment of primary lung cancer based on data mining[J]. Journal of Hunan University of Chinese Medicine, 2022, 42(08): 1242-1246.

WANG L, CHEN W, LI M, et al. A review of the ethnopharmacology, phytochemistry, pharmacology, and quality control of Scutellaria barbata D. Don[J]. J Ethnopharmacol, 2020, 254: 112260.

NING N, NAN Y, CHEN G, et al. Anti-Tumor Effects and Toxicity Reduction Mechanisms of Prunella vulgaris: A Comprehensive Review[J]. Molecules, 2024, 29(8).

CHEN W W, GONG K K, YANG L J, et al. Scutellariabarbata D. Don extraction selectively targets stemness-prone NSCLC cells by attenuating SOX2 / SMO/GLI1 network loop[J]. J Ethnopharmacol, 2021, 265: 113295.

ZHU J, ZHANG W, ZHANG Y, et al. Effects of Spica prunellae on caspase-3-associated proliferation and apoptosis in human lung cancer cells in vitro[J]. J Cancer Res Ther, 2018, 14(4): 760-763.

GUO H, DING H, TANG X, et al. Quercetin induces pro-apoptotic autophagy via SIRT1/AMPK signaling pathway in human lung cancer cell lines A549 and H1299 in vitro[J]. Thorac Cancer, 2021, 12(9): 1415-1422.

ZHOU B, YANG Y, PANG X, et al. Quercetin inhibits DNA damage responses to induce apoptosis via SIRT5/PI3K/AKT pathway in non-small cell lung cancer[J]. Biomed Pharmacother, 2023, 165: 115071.

ZHANG J, MA Y. Luteolin as a potential therapeutic candidate for lung cancer: Emerging preclinical evidence[J]. Biomed Pharmacother, 2024, 176: 116909.

GUO J, JIN G, HU Y, et al. Wogonin Restrains the Malignant Progression of Lung Cancer Through Modulating MMP1 and PI3K/AKT Signaling Pathway[J]. Protein Pept Lett, 2023, 30(1): 25-34.

WANG R, DENG Z, ZHU Z, et al. Kaempferol promotes non-small cell lung cancer cell autophagy via restricting Met pathway[J]. Phytomedicine, 2023, 121: 155090.

LI J, ZHANG D, WANG S, et al. Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer[J]. J Adv Res, 2024.

WANG Y, GOH K Y, CHEN Z, et al. A Novel TP53 Gene Mutation Sustains Non-Small Cell Lung Cancer through Mitophagy[J]. Cells, 2022, 11(22).

XU H, MA H, ZHA L, et al. Genistein promotes apoptosis of lung cancer cells through the IMPDH2/AKT1 pathway[J]. Am J Transl Res, 2022, 14(10): 7040-7051.

XU H, MA H, ZHA L, et al. Genistein promotes apoptosis of lung cancer cells through the IMPDH2/AKT1 pathway[J]. Am J Transl Res, 2022, 14(10): 7040-7051.

HONG C, MENG Y, QIU A, et al. Downregulated CDK10 promotes cancer progression and radioresistance in lung cancer through activating the JNK/c-Jun signaling pathway[J]. BMB Rep, 2024, 57(7): 336-341.

NIU M, ZHANG B, LI L, et al. Targeting HSP90 Inhibits Proliferation and Induces Apoptosis Through AKT1/ERK Pathway in Lung Cancer[J]. Front Pharmacol, 2021, 12: 724192.

IKSEN, POTHONGSRISIT S, PONGRAKHANANON V. Targeting the PI3K/AKT/mTOR Signaling Pathway in Lung Cancer: An Update Regarding Potential Drugs and Natural Products[J]. Molecules, 2021, 26(13).

Downloads

Published

2024-09-26

How to Cite

Liu, H., & Han, L. (2024). Exploring the Mechanism of Action of the "Scutellaria Barbata D.Don-Prunella Vulgaris L." Herb Pair in the Treatment of Lung Cancer Using Network Pharmacology and Molecular Docking Techniques. Journal of Contemporary Medical Practice, 6(9), 138–148. https://doi.org/10.53469/jcmp.2024.06(09).26